Proficio Capital Partners’s Neurocrine Biosciences NBIX Stock Holding History

Proficio Capital Partners’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-106	Closed	-$9K	–	1019
2019 Q2	$9K	Buy	106 +39	+58%	+$3.2K	﹤0.01%	977
2019 Q1	$6K	Buy	67 +6	+10%	+$501	﹤0.01%	1061
2018 Q4	$4K	Hold	61	–	–	﹤0.01%	904
2018 Q3	$7K	Hold	61	–	–	﹤0.01%	890
2018 Q2	$6K	Hold	61	–	–	﹤0.01%	954
2018 Q1	$5K	Hold	61	–	–	﹤0.01%	1006
2017 Q4	$5K	Buy	61 +5	+9%	+$341	﹤0.01%	977
2017 Q3	$3K	Hold	56	–	–	﹤0.01%	1036
2017 Q2	$3K	Hold	56	–	–	﹤0.01%	1050
2017 Q1	$3K	Buy	+56	New	+$2.4K	﹤0.01%	1082
2016 Q4	–	Sell	-11	Closed	-$1K	–	1164
2016 Q3	$1K	Buy	+11	New	+$548	﹤0.01%	993

Other funds holding NBIX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Proficio Capital Partners's NBIX Position: Q3 2019 in Review

Proficio Capital Partners sold out of Neurocrine Biosciences (NBIX) in Q3 2019, closing a stake of 106 shares — an estimated $9K sold.

Proficio Capital Partners first reported a position in NBIX in Q3 2016 and held it in 11 quarters. The position peaked at $9K in Q2 2019. 333 funds tracked by Wall St. Rank hold NBIX as of Q3 2019.

Proficio Capital Partners reported no remaining Neurocrine Biosciences position as of Q3 2019 after selling out during the quarter.
Proficio Capital Partners sold 106 Neurocrine Biosciences shares in Q3 2019, an estimated $9K.
Proficio Capital Partners first reported a position in Neurocrine Biosciences in Q3 2016 and held it in 11 quarters.
Proficio Capital Partners's Neurocrine Biosciences position peaked at $9K in Q2 2019.
333 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.